Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis
Exosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating inflammatory and autoimmune diseases. The aim of this study was to identify exosomal candidate proteins that are related to other inflammatory parameter...
Saved in:
Published in: | Arthritis research & therapy Vol. 19; no. 1; p. 119 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
BioMed Central Ltd
31-05-2017
BioMed Central BMC |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Exosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating inflammatory and autoimmune diseases. The aim of this study was to identify exosomal candidate proteins that are related to other inflammatory parameters in rheumatoid arthritis (RA).
The study population consisted of 60 patients with RA: 30 in the clinical remission (CR) group with a Disease Activity Score in 28 joints based on erythrocyte sedimentation rate (DAS28-ESR) ≤2.6 and 30 in the non-clinical remission (non-CR) group with a DAS28-ESR >2.6. Preparation of exosomes from patient serum samples was performed with the ExoQuick kit, and protein identification/quantification was performed using tandem mass tag labeling/mass spectrometry and an enzyme-linked immunosorbent assay. Comparisons between groups were made using Student's t test or the Mann-Whitney U test, as appropriate. Spearman's correlation coefficients (ρ) were calculated.
We identified six candidate proteins. Exosomal levels of amyloid A (AA) and lymphatic vessel endothelial hyaluronic acid receptor-1 (LYVE-1) differed between the CR and non-CR groups. Both serum and exosomal AA levels were higher in the non-CR group than in the CR group (p = 0.001). Significant positive correlations were found between exosomal AA and C-reactive protein (CRP) as well as between serum AA and CRP (ρ = 0.614, p = 0.001, and ρ = 0.624, p = 0.001, respectively). Although serum levels of LYVE-1 did not differ between the non-CR and CR groups, exosomal levels of LYVE-1 were lower in the non-CR group than in the CR group (p = 0.01). We identified positive correlations between serum/exosomal LYVE-1 and CRP only in the non-CR group (serum ρ = 0.376, p = 0.04; exosome ρ = 0.545, p = 0.002).
Exosomal LYVE-1 shows potential for use as an additional marker of disease activity in patients with RA, and exosomes may carry other useful markers for RA. |
---|---|
AbstractList | Exosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating inflammatory and autoimmune diseases. The aim of this study was to identify exosomal candidate proteins that are related to other inflammatory parameters in rheumatoid arthritis (RA).
The study population consisted of 60 patients with RA: 30 in the clinical remission (CR) group with a Disease Activity Score in 28 joints based on erythrocyte sedimentation rate (DAS28-ESR) ≤2.6 and 30 in the non-clinical remission (non-CR) group with a DAS28-ESR >2.6. Preparation of exosomes from patient serum samples was performed with the ExoQuick kit, and protein identification/quantification was performed using tandem mass tag labeling/mass spectrometry and an enzyme-linked immunosorbent assay. Comparisons between groups were made using Student's t test or the Mann-Whitney U test, as appropriate. Spearman's correlation coefficients (ρ) were calculated.
We identified six candidate proteins. Exosomal levels of amyloid A (AA) and lymphatic vessel endothelial hyaluronic acid receptor-1 (LYVE-1) differed between the CR and non-CR groups. Both serum and exosomal AA levels were higher in the non-CR group than in the CR group (p = 0.001). Significant positive correlations were found between exosomal AA and C-reactive protein (CRP) as well as between serum AA and CRP (ρ = 0.614, p = 0.001, and ρ = 0.624, p = 0.001, respectively). Although serum levels of LYVE-1 did not differ between the non-CR and CR groups, exosomal levels of LYVE-1 were lower in the non-CR group than in the CR group (p = 0.01). We identified positive correlations between serum/exosomal LYVE-1 and CRP only in the non-CR group (serum ρ = 0.376, p = 0.04; exosome ρ = 0.545, p = 0.002).
Exosomal LYVE-1 shows potential for use as an additional marker of disease activity in patients with RA, and exosomes may carry other useful markers for RA. Exosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating inflammatory and autoimmune diseases. The aim of this study was to identify exosomal candidate proteins that are related to other inflammatory parameters in rheumatoid arthritis (RA). The study population consisted of 60 patients with RA: 30 in the clinical remission (CR) group with a Disease Activity Score in 28 joints based on erythrocyte sedimentation rate (DAS28-ESR) [less than or equai to]2.6 and 30 in the non-clinical remission (non-CR) group with a DAS28-ESR >2.6. Preparation of exosomes from patient serum samples was performed with the ExoQuick kit, and protein identification/quantification was performed using tandem mass tag labeling/mass spectrometry and an enzyme-linked immunosorbent assay. Comparisons between groups were made using Student's t test or the Mann-Whitney U test, as appropriate. Spearman's correlation coefficients ([rho]) were calculated. We identified six candidate proteins. Exosomal levels of amyloid A (AA) and lymphatic vessel endothelial hyaluronic acid receptor-1 (LYVE-1) differed between the CR and non-CR groups. Both serum and exosomal AA levels were higher in the non-CR group than in the CR group (p = 0.001). Significant positive correlations were found between exosomal AA and C-reactive protein (CRP) as well as between serum AA and CRP ([rho] = 0.614, p = 0.001, and [rho] = 0.624, p = 0.001, respectively). Although serum levels of LYVE-1 did not differ between the non-CR and CR groups, exosomal levels of LYVE-1 were lower in the non-CR group than in the CR group (p = 0.01). We identified positive correlations between serum/exosomal LYVE-1 and CRP only in the non-CR group (serum [rho] = 0.376, p = 0.04; exosome [rho] = 0.545, p = 0.002). Exosomal LYVE-1 shows potential for use as an additional marker of disease activity in patients with RA, and exosomes may carry other useful markers for RA. Background Exosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating inflammatory and autoimmune diseases. The aim of this study was to identify exosomal candidate proteins that are related to other inflammatory parameters in rheumatoid arthritis (RA). Methods The study population consisted of 60 patients with RA: 30 in the clinical remission (CR) group with a Disease Activity Score in 28 joints based on erythrocyte sedimentation rate (DAS28-ESR) [less than or equai to]2.6 and 30 in the non-clinical remission (non-CR) group with a DAS28-ESR >2.6. Preparation of exosomes from patient serum samples was performed with the ExoQuick kit, and protein identification/quantification was performed using tandem mass tag labeling/mass spectrometry and an enzyme-linked immunosorbent assay. Comparisons between groups were made using Student's t test or the Mann-Whitney U test, as appropriate. Spearman's correlation coefficients ([rho]) were calculated. Results We identified six candidate proteins. Exosomal levels of amyloid A (AA) and lymphatic vessel endothelial hyaluronic acid receptor-1 (LYVE-1) differed between the CR and non-CR groups. Both serum and exosomal AA levels were higher in the non-CR group than in the CR group (p = 0.001). Significant positive correlations were found between exosomal AA and C-reactive protein (CRP) as well as between serum AA and CRP ([rho] = 0.614, p = 0.001, and [rho] = 0.624, p = 0.001, respectively). Although serum levels of LYVE-1 did not differ between the non-CR and CR groups, exosomal levels of LYVE-1 were lower in the non-CR group than in the CR group (p = 0.01). We identified positive correlations between serum/exosomal LYVE-1 and CRP only in the non-CR group (serum [rho] = 0.376, p = 0.04; exosome [rho] = 0.545, p = 0.002). Conclusions Exosomal LYVE-1 shows potential for use as an additional marker of disease activity in patients with RA, and exosomes may carry other useful markers for RA. Keywords: Exosomes, LYVE-1, Rheumatoid arthritis, Amyloid A, Biomarker Background Exosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating inflammatory and autoimmune diseases. The aim of this study was to identify exosomal candidate proteins that are related to other inflammatory parameters in rheumatoid arthritis (RA). Methods The study population consisted of 60 patients with RA: 30 in the clinical remission (CR) group with a Disease Activity Score in 28 joints based on erythrocyte sedimentation rate (DAS28-ESR) ≤2.6 and 30 in the non-clinical remission (non-CR) group with a DAS28-ESR >2.6. Preparation of exosomes from patient serum samples was performed with the ExoQuick kit, and protein identification/quantification was performed using tandem mass tag labeling/mass spectrometry and an enzyme-linked immunosorbent assay. Comparisons between groups were made using Student’s t test or the Mann-Whitney U test, as appropriate. Spearman’s correlation coefficients (ρ) were calculated. Results We identified six candidate proteins. Exosomal levels of amyloid A (AA) and lymphatic vessel endothelial hyaluronic acid receptor-1 (LYVE-1) differed between the CR and non-CR groups. Both serum and exosomal AA levels were higher in the non-CR group than in the CR group (p = 0.001). Significant positive correlations were found between exosomal AA and C-reactive protein (CRP) as well as between serum AA and CRP (ρ = 0.614, p = 0.001, and ρ = 0.624, p = 0.001, respectively). Although serum levels of LYVE-1 did not differ between the non-CR and CR groups, exosomal levels of LYVE-1 were lower in the non-CR group than in the CR group (p = 0.01). We identified positive correlations between serum/exosomal LYVE-1 and CRP only in the non-CR group (serum ρ = 0.376, p = 0.04; exosome ρ = 0.545, p = 0.002). Conclusions Exosomal LYVE-1 shows potential for use as an additional marker of disease activity in patients with RA, and exosomes may carry other useful markers for RA. Abstract Background Exosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating inflammatory and autoimmune diseases. The aim of this study was to identify exosomal candidate proteins that are related to other inflammatory parameters in rheumatoid arthritis (RA). Methods The study population consisted of 60 patients with RA: 30 in the clinical remission (CR) group with a Disease Activity Score in 28 joints based on erythrocyte sedimentation rate (DAS28-ESR) ≤2.6 and 30 in the non-clinical remission (non-CR) group with a DAS28-ESR >2.6. Preparation of exosomes from patient serum samples was performed with the ExoQuick kit, and protein identification/quantification was performed using tandem mass tag labeling/mass spectrometry and an enzyme-linked immunosorbent assay. Comparisons between groups were made using Student’s t test or the Mann-Whitney U test, as appropriate. Spearman’s correlation coefficients (ρ) were calculated. Results We identified six candidate proteins. Exosomal levels of amyloid A (AA) and lymphatic vessel endothelial hyaluronic acid receptor-1 (LYVE-1) differed between the CR and non-CR groups. Both serum and exosomal AA levels were higher in the non-CR group than in the CR group (p = 0.001). Significant positive correlations were found between exosomal AA and C-reactive protein (CRP) as well as between serum AA and CRP (ρ = 0.614, p = 0.001, and ρ = 0.624, p = 0.001, respectively). Although serum levels of LYVE-1 did not differ between the non-CR and CR groups, exosomal levels of LYVE-1 were lower in the non-CR group than in the CR group (p = 0.01). We identified positive correlations between serum/exosomal LYVE-1 and CRP only in the non-CR group (serum ρ = 0.376, p = 0.04; exosome ρ = 0.545, p = 0.002). Conclusions Exosomal LYVE-1 shows potential for use as an additional marker of disease activity in patients with RA, and exosomes may carry other useful markers for RA. BACKGROUNDExosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating inflammatory and autoimmune diseases. The aim of this study was to identify exosomal candidate proteins that are related to other inflammatory parameters in rheumatoid arthritis (RA).METHODSThe study population consisted of 60 patients with RA: 30 in the clinical remission (CR) group with a Disease Activity Score in 28 joints based on erythrocyte sedimentation rate (DAS28-ESR) ≤2.6 and 30 in the non-clinical remission (non-CR) group with a DAS28-ESR >2.6. Preparation of exosomes from patient serum samples was performed with the ExoQuick kit, and protein identification/quantification was performed using tandem mass tag labeling/mass spectrometry and an enzyme-linked immunosorbent assay. Comparisons between groups were made using Student's t test or the Mann-Whitney U test, as appropriate. Spearman's correlation coefficients (ρ) were calculated.RESULTSWe identified six candidate proteins. Exosomal levels of amyloid A (AA) and lymphatic vessel endothelial hyaluronic acid receptor-1 (LYVE-1) differed between the CR and non-CR groups. Both serum and exosomal AA levels were higher in the non-CR group than in the CR group (p = 0.001). Significant positive correlations were found between exosomal AA and C-reactive protein (CRP) as well as between serum AA and CRP (ρ = 0.614, p = 0.001, and ρ = 0.624, p = 0.001, respectively). Although serum levels of LYVE-1 did not differ between the non-CR and CR groups, exosomal levels of LYVE-1 were lower in the non-CR group than in the CR group (p = 0.01). We identified positive correlations between serum/exosomal LYVE-1 and CRP only in the non-CR group (serum ρ = 0.376, p = 0.04; exosome ρ = 0.545, p = 0.002).CONCLUSIONSExosomal LYVE-1 shows potential for use as an additional marker of disease activity in patients with RA, and exosomes may carry other useful markers for RA. |
ArticleNumber | 119 |
Audience | Academic |
Author | Yoo, Jihyung Lim, Mikyung Choi, Eun-Hye Kim, Soon Ae Sheen, Donghyuk Lee, Sang Kwang |
Author_xml | – sequence: 1 givenname: Jihyung surname: Yoo fullname: Yoo, Jihyung organization: Department of Internal Medicine, School of Medicine, Eulji University, Daejeon, Korea – sequence: 2 givenname: Sang Kwang surname: Lee fullname: Lee, Sang Kwang organization: Eulji Medi-Bio Research Institute, Eulji University, Daejeon, Korea – sequence: 3 givenname: Mikyung surname: Lim fullname: Lim, Mikyung organization: Department of Internal Medicine, School of Medicine, Eulji University, Daejeon, Korea – sequence: 4 givenname: Donghyuk surname: Sheen fullname: Sheen, Donghyuk organization: Department of Internal Medicine, School of Medicine, Eulji University, Daejeon, Korea – sequence: 5 givenname: Eun-Hye surname: Choi fullname: Choi, Eun-Hye organization: Eulji Medi-Bio Research Institute, Eulji University, Daejeon, Korea – sequence: 6 givenname: Soon Ae surname: Kim fullname: Kim, Soon Ae email: sakim@eulji.ac.kr organization: Department of Pharmacology, School of Medicine, Eulji University, Daejeon, Korea. sakim@eulji.ac.kr |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28569211$$D View this record in MEDLINE/PubMed |
BookMark | eNptUstu1DAUjVARfcAHsEGW2LBJsR07sTdIVVWgUiU2sLYc-2biUWIPtjNl_oMPxsOU0kHIC1v3nnPuw-e8OvHBQ1W9JviSENG-T6TBHa8x6WrSNKyWz6ozwjpRt01LT568T6vzlNYYUyope1GdUsFbSQk5q37e_AgpzHpCet5NwVl0hbS3aNrNm1FnZ9AWUoIJgbchjzC5Ah13elpi8CWrTaFEMLDJIdYEbWLI4HxCOgLSKQXjdAaL7l0ekXUJdCpxk93W5R1yHsURllnnfWUd8xhddull9XzQU4JXD_dF9e3jzdfrz_Xdl0-311d3teEtzjXtekOAc2mF6Lp2sNADoXhggnacAGslZ7TRrTCWMM0s1xQ60xItB8MHwM1FdXvQtUGv1Sa6WcedCtqp34EQV6r05MwESve06RpDKDQt4xREz8ASyXoqeluKF60PB63N0s9gDfgc9XQkepzxblSrsFW8yDHMi8C7B4EYvi-QsppdMjBN2kNYkiISMyFlI_Z9v_0Hug5L9GVVe1T5cFws8Re10mUA54dQ6pq9qLriuKMdk1QU1OV_UOVYmJ0pfhtciR8RyIFgYkgpwvA4I8Fqb0t1sKUqPai9LZUsnDdPl_PI-OPD5he0I-FI |
CitedBy_id | crossref_primary_10_3390_cells10081860 crossref_primary_10_1016_j_semarthrit_2021_12_011 crossref_primary_10_1007_s10067_019_04533_1 crossref_primary_10_1016_j_phrs_2021_105680 crossref_primary_10_1007_s00018_021_04020_4 crossref_primary_10_1186_s12865_020_00344_1 crossref_primary_10_1007_s10787_022_01100_0 crossref_primary_10_1080_17843286_2021_1890451 crossref_primary_10_1186_s13287_019_1445_0 crossref_primary_10_1007_s12026_023_09448_3 crossref_primary_10_1016_j_autrev_2020_102511 crossref_primary_10_1016_j_bcp_2018_02_004 crossref_primary_10_1016_j_ejps_2022_106262 crossref_primary_10_3389_fimmu_2022_939433 crossref_primary_10_4252_wjsc_v12_i8_879 crossref_primary_10_3389_fimmu_2020_631299 crossref_primary_10_1007_s10067_021_05614_w crossref_primary_10_1038_s41598_019_47367_2 crossref_primary_10_3389_fimmu_2021_730089 crossref_primary_10_1016_j_intimp_2024_111604 crossref_primary_10_1089_ten_teb_2023_0208 crossref_primary_10_1016_j_trac_2024_117823 crossref_primary_10_1002_jcb_28499 crossref_primary_10_47360_1995_4484_2022_561_569 crossref_primary_10_1186_s41927_018_0041_8 crossref_primary_10_1155_2021_2924935 crossref_primary_10_1111_1756_185X_14021 crossref_primary_10_3389_fimmu_2022_731516 |
Cites_doi | 10.1186/ar78 10.1111/j.1600-0463.2004.apm11207-0811.x 10.1371/journal.pone.0066769 10.1021/pr200748h 10.1002/art.20711 10.1021/pr2012347 10.1016/j.semcdb.2015.01.001 10.4049/jimmunol.176.12.7385 10.3899/jrheum.080770 10.1002/art.33455 10.1002/elps.201200345 10.1016/S0140-6736(01)06075-5 10.1155/2012/978396 10.1002/art.27584 10.1186/s13075-016-1159-y 10.1016/j.bbrc.2016.07.124 10.3892/mmr.2014.2804 10.3899/jrheum.080755 10.4236/ojra.2016.63012 10.7150/jca.8486 10.3402/jev.v3.24641 10.1002/prca.201500064 10.1016/j.jprot.2010.06.006 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2017 BioMed Central Ltd. Copyright BioMed Central 2017 The Author(s). 2017 |
Copyright_xml | – notice: COPYRIGHT 2017 BioMed Central Ltd. – notice: Copyright BioMed Central 2017 – notice: The Author(s). 2017 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s13075-017-1334-9 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content (ProQuest) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1478-6362 |
EndPage | 119 |
ExternalDocumentID | oai_doaj_org_article_ab2373c12e36452e8b4ed194b28bd776 A507274928 10_1186_s13075_017_1334_9 28569211 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: ; grantid: 2015 EMBRIDJP01 – fundername: ; grantid: No. 2016M3A9B694241 |
GroupedDBID | --- -5E -5G -A0 -BR .GJ 0R~ 23N 2WC 3V. 4.4 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ ABUWG ACGFS ACJQM ACRMQ ADBBV ADINQ ADUKV AEGXH AENEX AFKRA AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK E3Z EBD EBLON ECM EIF EJD EMOBN F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE HZ~ IAO IHR INH INR ITC KQ8 M1P NPM O5R O5S O9- PGMZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SMD SOJ SV3 TR2 U2A UKHRP WOQ Z7U AAYXX AFPKN CITATION 7XB 8FK AHSBF AZQEC DWQXO K9. PQEST PQUKI 7X8 5PM |
ID | FETCH-LOGICAL-c560t-27bc1e559d88776fdebe120f482751e4695423a68cd14a4d5a2e7c61a9fc5fe03 |
IEDL.DBID | RPM |
ISSN | 1478-6362 1478-6354 |
IngestDate | Tue Oct 22 15:15:06 EDT 2024 Tue Sep 17 21:20:55 EDT 2024 Sat Oct 26 01:27:34 EDT 2024 Sat Nov 09 12:37:11 EST 2024 Tue Nov 19 21:12:20 EST 2024 Tue Nov 12 22:34:02 EST 2024 Thu Sep 12 17:57:08 EDT 2024 Wed Oct 16 00:58:27 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Biomarker Exosomes Rheumatoid arthritis LYVE-1 Amyloid A |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c560t-27bc1e559d88776fdebe120f482751e4695423a68cd14a4d5a2e7c61a9fc5fe03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452405/ |
PMID | 28569211 |
PQID | 1906360017 |
PQPubID | 42876 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ab2373c12e36452e8b4ed194b28bd776 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5452405 proquest_miscellaneous_1904899380 proquest_journals_1906360017 gale_infotracmisc_A507274928 gale_infotracacademiconefile_A507274928 crossref_primary_10_1186_s13075_017_1334_9 pubmed_primary_28569211 |
PublicationCentury | 2000 |
PublicationDate | 2017-05-31 |
PublicationDateYYYYMMDD | 2017-05-31 |
PublicationDate_xml | – month: 05 year: 2017 text: 2017-05-31 day: 31 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Arthritis research & therapy |
PublicationTitleAlternate | Arthritis Res Ther |
PublicationYear | 2017 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 25352049 - Mol Med Rep. 2015 Feb;11(2):1528-34 20601276 - J Proteomics. 2010 Sep 10;73(10):1907-20 24665348 - J Cancer. 2014 Mar 11;5(3):242-7 19411389 - J Rheumatol. 2009 Jul;36(7):1387-90 26172530 - Proteomics Clin Appl. 2016 Feb;10 (2):164-71 25598390 - Semin Cell Dev Biol. 2015 Feb;38:90-7 22844292 - Int J Rheumatol. 2012;2012:978396 25143819 - J Extracell Vesicles. 2014 Aug 04;3:null 23776697 - PLoS One. 2013 Jun 12;8(6):e66769 15563314 - APMIS. 2004 Jul-Aug;112(7-8):526-38 22188275 - J Proteome Res. 2012 Mar 2;11(3):1582-90 22076945 - Arthritis Rheum. 2012 Apr;64(4):1035-45 16511906 - J Rheumatol. 2006 Mar;33(3):497-500 11567728 - Lancet. 2001 Sep 15;358(9285):903-11 23161002 - Electrophoresis. 2012 Dec;33(24):3756-63 16751383 - J Immunol. 2006 Jun 15;176(12):7385-93 22563702 - J Proteome Res. 2012 Jun 1;11(6):3199-210 19487269 - J Rheumatol. 2009 Jul;36(7):1371-9 27492069 - Biochem Biophys Res Commun. 2016 Sep 16;478(2):643-8 20872595 - Arthritis Rheum. 2010 Sep;62(9):2569-81 18428785 - Curr Protoc Bioinformatics. 2007 Jan;Chapter 13:Unit 13.4 27852323 - Arthritis Res Ther. 2016 Nov 16;18(1):264 11062604 - Arthritis Res. 2000;2(2):142-4 15641046 - Arthritis Rheum. 2005 Jan;52(1):42-8 7516430 - J Rheumatol. 1994 Mar;21(3):425-9 HG Zhang (1334_CR3) 2006; 176 K Byun (1334_CR11) 2012; 33 JY Lee (1334_CR4) 2016; 18 DM Lee (1334_CR5) 2001; 358 MA Leeuwen van (1334_CR7) 1994; 21 T Xu (1334_CR12) 2006; 5 J Kim (1334_CR28) 2016; 478 C Shen (1334_CR19) 2015; 11 EM Bouta (1334_CR24) 2015; 38 Y Braun-Moscovici (1334_CR26) 2006; 33 C Raso (1334_CR16) 2012; 11 M Connolly (1334_CR17) 2012; 64 Z Li (1334_CR13) 2012; 11 D Seny de (1334_CR21) 2013; 8 T Sokka (1334_CR8) 2009; 36 S Kyu Park (1334_CR15) 2006; 5 K Nunomiya (1334_CR23) 2014; 5 D Cociorva (1334_CR14) 2007; Chapter 13 H Tsuno (1334_CR27) 2016; 10 D Aletaha (1334_CR10) 2010; 62 DG Jackson (1334_CR22) 2004; 112 KI Halilova (1334_CR9) 2012; 2012 LA Mulcahy (1334_CR2) 2014; 3 MH Buch (1334_CR25) 2005; 52 LJM Rump (1334_CR6) 2016; 1 R O’Hara (1334_CR20) 2000; 2 S Mathivanan (1334_CR1) 2010; 73 S Visvanathan (1334_CR18) 2009; 36 |
References_xml | – volume: 2 start-page: 142 year: 2000 ident: 1334_CR20 publication-title: Arthritis Res doi: 10.1186/ar78 contributor: fullname: R O’Hara – volume: 112 start-page: 526 year: 2004 ident: 1334_CR22 publication-title: APMIS doi: 10.1111/j.1600-0463.2004.apm11207-0811.x contributor: fullname: DG Jackson – volume: 8 start-page: e66769 year: 2013 ident: 1334_CR21 publication-title: PLoS One doi: 10.1371/journal.pone.0066769 contributor: fullname: D Seny de – volume: 33 start-page: 497 year: 2006 ident: 1334_CR26 publication-title: J Rheumatol contributor: fullname: Y Braun-Moscovici – volume: 11 start-page: 1582 year: 2012 ident: 1334_CR13 publication-title: J Proteome Res doi: 10.1021/pr200748h contributor: fullname: Z Li – volume: 52 start-page: 42 year: 2005 ident: 1334_CR25 publication-title: Arthritis Rheum doi: 10.1002/art.20711 contributor: fullname: MH Buch – volume: 11 start-page: 3199 year: 2012 ident: 1334_CR16 publication-title: J Proteome Res doi: 10.1021/pr2012347 contributor: fullname: C Raso – volume: 38 start-page: 90 year: 2015 ident: 1334_CR24 publication-title: Semin Cell Dev Biol doi: 10.1016/j.semcdb.2015.01.001 contributor: fullname: EM Bouta – volume: 176 start-page: 7385 year: 2006 ident: 1334_CR3 publication-title: J Immunol doi: 10.4049/jimmunol.176.12.7385 contributor: fullname: HG Zhang – volume: 36 start-page: 1387 year: 2009 ident: 1334_CR8 publication-title: J Rheumatol doi: 10.3899/jrheum.080770 contributor: fullname: T Sokka – volume: 64 start-page: 1035 year: 2012 ident: 1334_CR17 publication-title: Arthritis Rheum doi: 10.1002/art.33455 contributor: fullname: M Connolly – volume: 33 start-page: 3756 year: 2012 ident: 1334_CR11 publication-title: Electrophoresis doi: 10.1002/elps.201200345 contributor: fullname: K Byun – volume: 358 start-page: 903 year: 2001 ident: 1334_CR5 publication-title: Lancet doi: 10.1016/S0140-6736(01)06075-5 contributor: fullname: DM Lee – volume: 5 start-page: S199 issue: 10 Suppl year: 2006 ident: 1334_CR15 publication-title: Mol Cell Proteomics contributor: fullname: S Kyu Park – volume: 2012 start-page: 978396 year: 2012 ident: 1334_CR9 publication-title: Int J Rheumatol doi: 10.1155/2012/978396 contributor: fullname: KI Halilova – volume: Chapter 13 start-page: Unit 13.4 year: 2007 ident: 1334_CR14 publication-title: Curr Protoc Bioinforma contributor: fullname: D Cociorva – volume: 62 start-page: 2569 year: 2010 ident: 1334_CR10 publication-title: Arthritis Rheum doi: 10.1002/art.27584 contributor: fullname: D Aletaha – volume: 5 start-page: S174 issue: 10 Suppl year: 2006 ident: 1334_CR12 publication-title: Mol Cell Proteomics contributor: fullname: T Xu – volume: 18 start-page: 264 year: 2016 ident: 1334_CR4 publication-title: Arthritis Res Ther doi: 10.1186/s13075-016-1159-y contributor: fullname: JY Lee – volume: 478 start-page: 643 year: 2016 ident: 1334_CR28 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2016.07.124 contributor: fullname: J Kim – volume: 11 start-page: 1528 year: 2015 ident: 1334_CR19 publication-title: Mol Med Rep doi: 10.3892/mmr.2014.2804 contributor: fullname: C Shen – volume: 36 start-page: 1371 year: 2009 ident: 1334_CR18 publication-title: J Rheumatol doi: 10.3899/jrheum.080755 contributor: fullname: S Visvanathan – volume: 1 start-page: 74 year: 2016 ident: 1334_CR6 publication-title: Open J Rheumatol Autoimmune Dis doi: 10.4236/ojra.2016.63012 contributor: fullname: LJM Rump – volume: 5 start-page: 242 year: 2014 ident: 1334_CR23 publication-title: J Cancer doi: 10.7150/jca.8486 contributor: fullname: K Nunomiya – volume: 3 start-page: 24641 year: 2014 ident: 1334_CR2 publication-title: J Extracell Vesicles doi: 10.3402/jev.v3.24641 contributor: fullname: LA Mulcahy – volume: 21 start-page: 425 year: 1994 ident: 1334_CR7 publication-title: J Rheumatol contributor: fullname: MA Leeuwen van – volume: 10 start-page: 164 year: 2016 ident: 1334_CR27 publication-title: Proteomics Clin Appl doi: 10.1002/prca.201500064 contributor: fullname: H Tsuno – volume: 73 start-page: 1907 year: 2010 ident: 1334_CR1 publication-title: J Proteomics doi: 10.1016/j.jprot.2010.06.006 contributor: fullname: S Mathivanan |
SSID | ssj0022924 |
Score | 2.4189236 |
Snippet | Exosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating... Background Exosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating... BACKGROUNDExosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating... Abstract Background Exosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 119 |
SubjectTerms | Adult Aged Amyloid A Arthritis Arthritis, Rheumatoid - metabolism Arthritis, Rheumatoid - pathology Biological markers Biomarker Biomarkers Biomarkers - analysis Blood Cancer Chromatography Cytokines Development and progression Disease Exosomes Exosomes - metabolism Female Health risk assessment Humans LYVE-1 Mass spectrometry MicroRNA Middle Aged Pathogenesis Proteins Proteomics Rheumatoid arthritis Scientific imaging Serum Amyloid A Protein - analysis Serum Amyloid A Protein - metabolism Tumor necrosis factor-TNF Vesicular Transport Proteins - analysis Vesicular Transport Proteins - metabolism |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB1BD4gLouUrtFRGQkJCiho73tg5bmGrXuACSNwsx3a0K22z1aap6P_gB3fG8a4aceDCMbGjOH4z9rx4_AzwwWteeF-4XMk65LLyKm8cXlZOiFqEogxRwPTyu_r2S39ZkEzO_qgvygkb5YHHjjuzjShV6bgItGAmgm5k8Mi8G6Ebr9Qotl3oHZlKVAvfI9MaJtfVWY8jtaIkNZUjJ5N5PZmFolj_30Pygzlpmi_5YAK6eA7PUuTI5mOLD-FR6I7gyde0Nv4C_ix-b_rNFVaxV8jCV57Nme08W98hYKTLym5JJ3zNQudp29UaLY8t7-x6iPK4zDp8BMe_cI00POcsKjisup7ZbWA2oRg8oz-3LK3rMNoWQadPsFXHtsswYPxLb8ZuXUa1pJfw82Lx4_Nlns5cyB3GPje5UI3jAWmGx9FHVa1HkLkoWlILnfGAZHqGAZittPNcWulnVgTlKm7rlvLWivIVHHSbLrwB5msvm9bqIhRa-rZuBHfeNbTug3GOtRl82mFgrkdpDRMpia7MCJhBwAwBZuoMzgmlfUVSxY430FZMshXzL1vJ4CNhbMh3EUhn0xYEbC-pYJk5BsfI0muhMziZ1ESfc9PinZWY5PO9wdCKxNewzRm83xfTk5TH1oXNEOtIZLilLjJ4PRrV_pOEnlU18vEM1MTcJt88LelWy6gITgfFY-T99n900jE8FeQoMUPiBA5utkN4B497P5xGH7sHvQ0tkw priority: 102 providerName: Directory of Open Access Journals |
Title | Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28569211 https://www.proquest.com/docview/1906360017 https://search.proquest.com/docview/1904899380 https://pubmed.ncbi.nlm.nih.gov/PMC5452405 https://doaj.org/article/ab2373c12e36452e8b4ed194b28bd776 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA7OPogv4t3qOkQQBKE7TZq26eO4zrIiK4IKvoU0yTiFTjtMt-L-D3-w52TSYYtvPs4koUnPJefrOflCyBsrWWJtYuJClC4WuS3iysDP3HBecpekzhOYXn4tPv-QH1ZIk5ONZ2F80b6p6rO22Z619cbXVu62ZjHWiS2-XJ3jvdgQaCxmZAax4QjRA8qCR_hUsgB4BLupCKlMJvNFDw67wFq1IgZoJmKkDOUyy0vO2GRf8vT9_zrpW7vUtILy1pZ08YDcD7EkXR7m_JDcce0jcvcqZMsfkz-r313fbaGL3gIury1dUt1a2tyACJGplf5C5vCGutbiQawGdJFubnQzeMJcqg0MAY_odgDMY0Y9p0Pd9lTvHdVBrs5S_JZLQ6aH4kEJvI-C1i3db9wAETE-GV7sxvMnPSHfL1bfzi_jcAtDbCAauo55URnmAHhY8EdFvrYgdsaTNfKHZswBvM4gJNO5NJYJLWymuStMznS5xkq2JH1KTtqudc8JtaUV1VrLxCVS2HVZcWasqTATBJGP1hF5N8pA7Q5kG8qDFJmrg-wUyE6h7FQZkfcopWNH5Mn2f3T7nypoi9IVT4vUMO4w3cqdrISzrBQVl5WF1UTkLcpYoTWDII0OhxJgvsiLpZYQLgNuL7mMyOmkJ1ihmTaPWqKCF-gVBFtIxwZzjsjrYzOOxMq21nWD7yMA86Yyicizg1IdlzTqZkSKibpN1jxtAZPxHOHBRF7898iX5B5HQ_GFEqfk5Ho_uFdk1tthDsjj46e5_3ox97b3F6plMhs |
link.rule.ids | 230,315,729,782,786,866,887,2108,27935,27936,53803,53805 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6xIQEv_P4RGGAkJCSkrLHrJM5jGZ2KWCckhsSb5dgurdSmVbsi9n_wB3PnOtUi3vbY2lZi3efzfbnzZ4D3TvHMucympax8KgtXprXFn4UVohI-6_sgYDr6Xp7_VJ-HJJOTt2dhQtG-rWfHzXxx3MymobZytbC9tk6s9218QvdiY6DRO4DbuF6zfkvSI8_Ch4RkskSChPupjMlMroreBl12SdVqZYrkTKYkGipUXlSC887OFAT8_3fT1_apbg3ltU3p9MENp_MQ7scolA12zY_glm8ew51xzLM_gb_DP8vNcoFdzAIZ_cyxATONY_MrND5pvLLfpDk-Z75xdIRrjihm0ysz3wapXWYsDkFf6ldI6VPOghrErNkws_bMRER4x-grMIs5IkZHLOgmCzZr2HrqtxhL05NxDtOgvPQUfpwOL05Gaby_IbUYR12moqwt90hZHHqyspg4BAwX2YSUR3PukZjnGMyZQlnHpZEuN8KXtuCmmlANXNZ_BofNsvEvgLnKyXpiVOYzJd2kqgW3ztaUQ8KYyZgEPra206udTIcO9EYVemdzjTbXZHNdJfCJrLvvSArb4Y_l-peOhtGmFv2yb7nwlKgVXtXSO17JWqja4WwS-EDY0OQHEADWxOMM-L6kqKUHGGgj46-ESuCo0xPXr-02t-jS0X9sNIZpJOSG75zAu30zjaSauMYvt6GPRLaMCyCB5zsw7qfUYjqBsgPTzpy7LYjOoC4e0fjyxiPfwt3RxfhMn305__oK7glabKHc4ggOL9db_xoONm77JqzZfwk5RbE |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fa9swED7WDspe9vuHu27TYDAYuLYUxZYfszahY2spbIO9CVmSl0DihKQp6_-xP3h3ihJq9rY9JpKwxX063ec7fQJ45xTPncttWsrKp7JwZVpb_FlYISrh854PAqZnX8uLH-p0SDI5u6u-QtG-rSfH7XR23E7GobZyMbPZtk4suzw_oXuxMdDIFq7J9uAurtm8vyXqkWvhg0JCWSJJwj1VxoQmV0W2QrddUsVamSJBkykJhwrVLyrBeWd3CiL-f7vqW3tVt47y1sY0evAfU3oI92M0ygabLo_gjm8fw8F5zLc_gd_DX_PVfIZdzAyZ_cSxATOtY9MbBAFpvbJr0h6fMt86Oso1RTSz8Y2ZroPkLjMWh6BP9Quk9ilnQRVi0q6YWXpmIjK8Y_Q1mMVcEaOjFnSjBZu0bDn2a4yp6ck4j3FQYHoK30fDbydnabzHIbUYT12loqwt90hdHHq0smgcAoeLvCEF0j73SND7GNSZQlnHpZGub4QvbcFN1VAtXN57BvvtvPUvgLnKyboxKve5kq6pasGtszXlkjB2MiaBD1v76cVGrkMHmqMKvbG7RrtrsruuEvhIFt51JKXt8Md8-VNH42hTi17Zs1x4StgKr2rpHa9kLVTtcDYJvCd8aPIHCAJr4rEGfF9S1tIDDLiR-VdCJXDU6Ynr2HabtwjT0Y-sNIZrJOiG75zA210zjaTauNbP16GPRNaMiyCB5xtA7qa0xXUCZQeqnTl3WxChQWU8IvLwn0e-gYPL05H-8uni80u4J2i9haqLI9i_Wq79K9hbufXrsGz_ACMCSDE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosomal+amyloid+A+and+lymphatic+vessel+endothelial+hyaluronic+acid+receptor-1+proteins+are+associated+with+disease+activity+in+rheumatoid+arthritis&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Yoo%2C+Jihyung&rft.au=Lee%2C+Sang+Kwang&rft.au=Lim%2C+Mikyung&rft.au=Sheen%2C+Donghyuk&rft.date=2017-05-31&rft.pub=BioMed+Central&rft.issn=1478-6354&rft.eissn=1478-6362&rft.volume=19&rft_id=info:doi/10.1186%2Fs13075-017-1334-9 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon |